Step 8: preparation of sodium [5-(3-(tert-butoxycarbonylamino)propyl)-4,9-dioxo-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-en-10-yl] sulfate (10h)
Using the procedure described in example 3 (step 14), 10-allyloxy-5-(3-(tert-butoxycarbonylamino)propyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10g) (186 mg, 0.453 mmol) was converted to sodium [5-(3-(tert-butoxycarbonylamino)propyl)-4,9-dioxo-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-en-10-yl] sulfate (10h) (105 mg, 0.222 mmol, 49%).